Arterial calcification is a phenotype of vascular repair in atherosclerosis, diabetes, hyperphosphatemic renal failure, and aging that promotes mortality. Arterial calcification is an active and organized process, switched on by chondrocytic and osteoblastic differentiation of intra-arterial progenitors. Chondrogenesis is modulated by the metabolism of GSH. Vanin-1 pantetheinase suppresses GSH synthesis. Vanin-1 is induced by a variety of inflammatory stressors and promotes granuloma formation and intestinal inflammation. Vanin-1 suppresses PPARgamma expression and signaling, and vanin-1 thereby """"""""licenses"""""""" pro-inflammatory cytokine expression. We observe increased chondrogenic potential of mesenchymal precursor cells linked with both PPi deficiency and driven by increased vanin-1 pantetheinase activity, cysteamine generation, and consequent GSH depletion. Vanin-1 knockout also blunts phosphate donor-induced chondrogenic differentiation and calcification in PPi-deficient arterial explants. PPARgamma suppresses bone formation and inhibits calcification by vascular cells. PPARgamma agonism also blunts experimental aortic media calcification. Our core hypothesis is that vanin-1 and modulation of PPARgamma are central and linked threads by which PPi/Pi imbalance, bone morphogens, and inflammation drive intra- arterial chondro-osseous differentiation and distinct phenotypes of primarily intimal or tunica media calcification. Here, we specifically aim to: 1. Define the core paracrine and autocrine mechanisms by which vanin-1 promotes switching on chondrogenic trans- differentiation in arterial SMCs. 2. Test the hypothesis that vanin-1 deficiency delays or prevents intra-arterial chondrogenesis and lethal artery media calcification in MGP deficient mice. 3. Test the hypothesis that SMC PPARgamma deficiency is sufficient to increase artery calcification in MGP deficient mice without primary dysregulation of vanin-1. 4. Test the hypothesis that generalized vanin-1 deficiency and SMC-specific PPARgamma deficiency exert opposite effects on atherosclerotic lesion calcification in chow-fed, aged apoE ko mice. Completion of these studies will provide novel insight and identification of vanin-1 as a potential new therapeutic target for arterial calcification.

Public Health Relevance

Lay summary Arterial calcification is one of the potential outcomes of blood vessel repair in atherosclerosis, diabetes, chronic kidney disease, and aging. Artery calcification promotes mortality in these conditions and our objective is to identify new targets for therapies. In this project, we will define and test proposed mechanisms whereby linked changes in an enzyme (Vanin-1) involved in defense against oxidative stress, and the gene expression regulator PPARgamma, promote arterial calcification by switching on cartilage and bone formation in diseased arteries.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Fleg, Jerome
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Veterans Medical Research Fdn/San Diego
San Diego
United States
Zip Code
Terkeltaub, Robert (2014) Apolipoprotein a-I at the interface of vascular inflammation and arthritis. Arterioscler Thromb Vasc Biol 34:474-6
Zhao, Xianling; Petursson, Freyr; Viollet, Benoit et al. (2014) Peroxisome proliferator-activated receptor ? coactivator 1? and FoxO3A mediate chondroprotection by AMP-activated protein kinase. Arthritis Rheumatol 66:3073-82
Serrano, Ramon L; Yu, Weifang; Terkeltaub, Robert (2014) Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expression. Atherosclerosis 233:493-502
Petursson, Freyr; Husa, Matt; June, Ron et al. (2013) Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes. Arthritis Res Ther 15:R77
Husa, Matt; Petursson, Freyr; Lotz, Martin et al. (2013) C/EBP homologous protein drives pro-catabolic responses in chondrocytes. Arthritis Res Ther 15:R218
Dammanahalli, K Jagadeesha; Stevens, Stephanie; Terkeltaub, Robert (2012) Vanin-1 pantetheinase drives smooth muscle cell activation in post-arterial injury neointimal hyperplasia. PLoS One 7:e39106
Nitschke, Yvonne; Baujat, Genevieve; Botschen, Ulrike et al. (2012) Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 90:25-39
Yu, Weifang; Liu-Bryan, Ru; Stevens, Stephanie et al. (2012) RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity. Atherosclerosis 222:417-25
Neogi, Tuhina; George, Jacob; Rekhraj, Sushma et al. (2012) Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal. Arthritis Rheum 64:327-38
Nitschke, Yvonne; Weissen-Plenz, Gabriele; Terkeltaub, Robert et al. (2011) Npp1 promotes atherosclerosis in ApoE knockout mice. J Cell Mol Med 15:2273-83

Showing the most recent 10 out of 32 publications